The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Jessica Karen Wong joins Fox Chase

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Jessica Karen Wong will join Fox Chase Cancer Center July 1 as assistant professor in the academic clinical track in the Department of Radiation Oncology.

Wong will join the staff upon completion of her radiation oncology residency program at Fox Chase, where she served as chief resident last year and won the RSNA Roentgen Resident/Fellow Research Award.

Before attending medical school, Wong earned her masters of engineering in biomedical engineering from the Harvard-MIT Division of Health Sciences and Technology. She received her medical degree from the University of Tennessee College of Medicine on multiple scholarships.

Table of Contents

YOU MAY BE INTERESTED IN

Podcast

How will FDA regulate psychedelics?

FDA has been taking a look at psychedelics as a potential treatment for psychiatric and substance abuse disorders, recently publishing a final guidance for drug sponsors conducting clinical trials of psychedelics, including psilocybin, LSD, and MDMA. 
PodcastThe Directors

The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long”

The United States has a translation problem. Scientific breakthroughs in oncology are accelerating, but clinical trial infrastructure hasn’t kept pace. 
By Paul Goldberg and Claire Marie Porter
Guest Editorial

Cancer progress is not reaching everyone. Native Nations must be part of the solution.

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.
By Rodney Haring
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account